To respond to the increasing obligation for traceability in the pharmaceutical industry, ADENTS demonstrated its Pharma Suite solution at the latest Pharmaceutical Serialisation and Traceability Summit in Geneva this year.
ADENTS, which sponsored the "CMO Challenges with Serialisation" round table, has recently become a leading player in this high-growth market. Its Pharma Suite solution identifies and affiliates each product in order to meet the regulatory requirements of serialisation in the life sciences sector. The solutions also address the increasingly important issues of parallel markets and counterfeit pharmaceutical and medical products.
ADENTS' software quickly adapts to all types of existing systems and equipment to optimize productivity and minimize costs. It is totally independent from hardware, MES, and ERP suppliers.
With over 20 years experience in the field of secure identity solutions, ADENTS is one of the few suppliers in a position to offer global solutions which can be adapted to life science companies' current enterprise systems. In addition, the company proposes complete solutions for all upcoming regulatory changes, including the Drug Supply Chain Security Act (DSCSA) which comes into force in January 2015.
Christophe Devins, CEO of ADENTS, commented, "With only 26% of companies having started to roll-out serialization solutions across multiple sites globally, the Pharmaceutical Serialisation and Traceability summit is a strategic forum for life science organizations to make important decisions to be in a position to comply with upcoming regulations. We are convinced that our Pharma Suite solution ticks all the boxes for an easily integrated and cost-effective global solution."
Jean-Luc Lasne, International Business Development & Alliance Director, added, "ADENTS recognizes the imminent need for companies to find a global, robust and reliable solution for their serialization and brand-protection system. Our mature Pharma Suite solution responds to all of these demands and goes further by being GAMP5 compliant and running at up to 650 boxes per minute."
ADENTS sponsored the "CMO Challenges with Serialisation" round table at the show and was able to showcase its Pharma Suite throughout the event.
Adents Pharma is a line of software solutions developed by ADENTS to satisfy all regulations regarding serialization and bringing production lines into compliance.
Adents Pharma Suite identifies and affiliates each individual product to satisfy the regulatory serialization requirements of players in the life science industry:
Founded in 2007, ADENTS produces unit identification software. The company currently has over fifty employees based in France, with offices in Paris and Lyon. A large number of prestigious companies have installed hundreds of ADENTS equipped production lines. Rapidly expanding on the international scene, the company is opening subsidiaries in Europe and in North America and aims at integrating around 150 new collaborators in the coming months.
With innovative software solutions that respond to rapidly evolving international standards, ADENTS is poised to become the leading player in this high-growth market.
